Views & Analysis | Perspectives on pharma industry issues

Patients

Beyond distance and stigma: AI's potential to democratise he...

Access to healthcare and health information remains vastly unequal, fuelled by factors like wealth, geography, language, and literacy.

R&D

Case Study: MHRA

Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.

R&D

pharmaphorum podcast episode 132a - woman on her phone listening to headphones

In vitro gametogenesis: the science has to be right, and it ...

In vitro gametogenesis (IVG) holds much potential for same-sex couples and women of a more advanced age struggling with infertility, but the question is whether we’re quite there yet.

Digital

Is digital therapeutics innovation enough for a sustainable ...

Treatments emerging from the digital therapeutics space were once greeted with optimism, due to the potential to aid patients’ health through technology, rather than pharmaceuticals.

Sales & Marketing

Sponsored

12 Questions with Michael Stevinson

Michael Stevinson is Global Agency Head at Caudex, an IPG Health Medical Communications company.

Market Access

Who delays NICE technology appraisals anyway?

Leela Barham looks at the speediness of NICE’s technology appraisals and ongoing efforts to hit the target of NICE publishing final guidance within 90 days of marketing authorisation.

Digital

Transforming clinical trials with open-source tech

Clinical trials historically struggled with several key inefficiencies, many of which became painfully apparent during the COVID-19 pandemic, such as the traditional paper-based, manual rev

Market Access

What are the key immigration changes facing the pharma indus...

It’s no secret that the UK life sciences sector is facing skills shortages – in a 2020 report, the Science Industry Partnership’s Life Sciences 2030 Skills Strategy predicted that 133,000 e

Sales & Marketing

Sponsored

12 Questions with Michael Stevinson

Michael Stevinson is Global Agency Head at Caudex, an IPG Health Medical Communications company.

Sales & Marketing

Sponsored

12 Questions with Pilar de la Rocha Mur

Pilar de la Rocha Mur is Head of Clinical Operations EMEA (Europe, Middle East, and Africa) at BeiGene.

Digital

Is digital therapeutics innovation enough for a sustainable ...

Treatments emerging from the digital therapeutics space were once greeted with optimism, due to the potential to aid patients’ health through technology, rather than pharmaceuticals.

Digital

Transforming clinical trials with open-source tech

Clinical trials historically struggled with several key inefficiencies, many of which became painfully apparent during the COVID-19 pandemic, such as the traditional paper-based, manual rev

Market Access

Who delays NICE technology appraisals anyway?

Leela Barham looks at the speediness of NICE’s technology appraisals and ongoing efforts to hit the target of NICE publishing final guidance within 90 days of marketing authorisation.

Market Access

What are the key immigration changes facing the pharma indus...

It’s no secret that the UK life sciences sector is facing skills shortages – in a 2020 report, the Science Industry Partnership’s Life Sciences 2030 Skills Strategy predicted that 133,000 e

Oncology

Warning signs for CAR-T after secondary cancer cases

CAR-T treatments emerged as a major success for the pharma industry when first approved in 2017, but this has been muddied by concerns over secondary malignancies.

Oncology

Women in life sciences: Miruna Sasu

On International Women’s Day, pharmaphorum looks back to an interview with Miruna Sasu, PhD, CEO of COTA, a real-world data company that is advancing generative AI models for cancer care.

Oncology

Sponsored

12 Questions with Jorge Reis-Filho

As Vice President of Cancer Biomarker Development at AstraZeneca, Jorge Reis-Filho seeks to develop and validate the next generation of mechanistically informed and clinically deployable bi

Patients

Beyond distance and stigma: AI's potential to democratise he...

Access to healthcare and health information remains vastly unequal, fuelled by factors like wealth, geography, language, and literacy.

Patients

Clinical trials: Their design, location, and, potentially, t...

Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.

Patients

Breaking down the challenges of donor recruitment and recall...

One key aspect of the biospecimen market (if not the most important) is the availability and accessibility of the donor pool for testing of both normal, healthy donors and disease state don

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D